• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Tumor-selective high LET and high RBE particles can overcome the radiation-resistant glioma stem cells

Research Project

  • PDF
Project/Area Number 23390355
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionOsaka Medical College

Principal Investigator

MIYATAKE Shin-Ichi  大阪医科大学, 医学部, 教授 (90209916)

Co-Investigator(Kenkyū-buntansha) KAWABATA Shinji  大阪医科大学, 医学部, 講師 (20340549)
MICHIUE Hiroyuki  岡山大学, 医歯薬総合研究科, 助教 (20572499)
KUROIWA Toshihiko  大阪医科大学, 医学部, 教授 (30178115)
KAJIMOTO Yoshinaga  大阪医科大学, 医学部, 教授 (30224413)
KIRIHATA Mitsunori  大阪府立大学, 21世紀科学研究機構, 教授 (60128767)
MASUNAGA Shin-ichirou  京都大学, 原子炉実験所, 教授 (80238914)
ONO Koji  京都大学, 原子炉実験所, 教授 (90122407)
Project Period (FY) 2011-04-01 – 2014-03-31
Keywordshigh LET / BNCT / glioma stem cell / 放射線抵抗性 / 癌幹細胞
Research Abstract

GSLC were induced from GBM cell line A172. The phenotypes of GSLCs were confirmed by stem cell markers. These cells were irradiated with 60Co gamma rays or reactor neutron beams. Under neutron beam irradiation, high-LET proton particles can be produced. Radiosensitivity was assessed by a CFA, and the DNA double-strand breaks (DSBs) were assessed by gamma-H2AX focus assay. In stem cell culture medium, GSLCs could form neurosphere-like cells and express neural stem cell markers, Sox2 and Musashi, abundantly in comparison with their parental cells. GSLCs were significantly more radioresistant to gamma rays than their parental cells, but neutron beams overcame this resistance. Twenty-four hours after irradiation with gamma rays, there were significantly fewer gamma-H2AX foci in A172 GSLCs than in their parental cultured cells, while there was no apparent difference following neutron beam irradiation. High-LET radiation can overcome the radioresistance of GSLCs.

  • Research Products

    (12 results)

All 2014 2013

All Journal Article (7 results) Presentation (5 results)

  • [Journal Article] High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation2014

    • Author(s)
      Hirota Y, Masunaga SI, Kondo N, Kawabata S, Hirakawa H, Yajima H, Fujimori A, Ono K, Kuroiwa T, Miyatake SI
    • Journal Title

      J Radiat Res

      Volume: 55(1) Pages: 75-83

  • [Journal Article] The roles of Platelet-Derived Growth Factors and their receptors in brain radiation necrosis2014

    • Author(s)
      Miyata T, Toho T, Nonoguchi N, Furuse M, Kuwabara H, Yoritsune E, Kawabata S, Kuroiwa T, and Miyatake S
    • Journal Title

      Radiation Oncology

      Volume: 9 Pages: 51

  • [Journal Article] Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients : four cases2014

    • Author(s)
      Miyatake SI, Kawabata S, Hiramatsu R, Furuse M, Kuroiwa T, Suzuki M
    • Journal Title

      Radiat Oncol

      Volume: 9(1) Pages: 6

  • [Journal Article] Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases2013

    • Author(s)
      Miyatake SI, Furuse M, Kawabata S, Maruyama T, Kumabe T, Kuroiwa T, Ono K
    • Journal Title

      Neuro Oncol

      Volume: 15(6) Pages: 650-5

  • [Journal Article] Symptomatic Radiation Necrosis Diagnosed by Amino Acid PET Motomasa Furuse2013

    • Author(s)
      Naosuke Nonoguchi, Shinji Kawabata, Erina Yoritsune, Masatsugu Takahashi, Taisuke Inomata, Toshihiko Kuroiwa and Shin-Ichi Miyatake
    • Journal Title

      Bevacizumab Treatment for Jpn J Clin Oncol

      Volume: 43(3) Pages: 337-41

  • [Journal Article] Boron neutron capture therapy for recurrent high-grade meningiomas2013

    • Author(s)
      Kawabata S, Hiramatsu R, Kuroiwa T, Ono K, Miyatake SI
    • Journal Title

      J Neurosurg

      Volume: 119(4) Pages: 837-44

  • [Journal Article] Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map2013

    • Author(s)
      Hiramatsu R, Kawabata S, Furuse M, Miyatake S, Kuroiwa T
    • Journal Title

      Radiat Oncol

      Volume: 8(1) Pages: 192

  • [Presentation] 悪性脳腫瘍に対するホウ素中性子捕捉療法の現状と未来2013

    • Author(s)
      宮武伸一
    • Organizer
      第31回日本脳腫瘍学会
    • Place of Presentation
      宮崎
    • Year and Date
      2013-12-09
  • [Presentation] Bevacizumab for progressive radiation necrosis with the nuclear medicine diagnosis : institutional results and ongoing nation-wide clinical trial2013

    • Author(s)
      Miyatake S
    • Organizer
      SNO meeting
    • Place of Presentation
      San Fransisco
    • Year and Date
      2013-11-23
  • [Presentation] 「症候性脳放射線壊死の核医学的診断とベバシズマブの静脈内投与による治療」薬事承認を目指した多施設共同研究2013

    • Author(s)
      宮武伸一, 他16 名
    • Organizer
      第3項先進医療 JASTRO 2013
    • Place of Presentation
      青森
    • Year and Date
      2013-10-20
  • [Presentation] 薬事承認を目指した多施設共同研究, 第3項先進医療「症候性脳放射線壊死の核医学的診断とベバシズマブの静脈内投与による治療」日本脳神経外科学会2013

    • Author(s)
      宮武伸一, 他16 名
    • Organizer
      第72回学術総会シンポジウム
    • Place of Presentation
      横浜
    • Year and Date
      2013-10-18
  • [Presentation] 症候性脳放射線壊死に対する診断と治療2013

    • Author(s)
      宮武伸一
    • Organizer
      第72回日本医学放射線学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2013-04-12

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi